We are live on
!
Find out more
CP
Cumberland Partners Portfolio holdings
AUM
$1.32B
1-Year Est. Return
27.83%
This Fund
S&P 500
This Quarter
Est. Return
+1.21%
1 Year Est. Return
+27.83%
3 Year Est. Return
+88.45%
5 Year Est. Return
+120.48%
10 Year Est. Return
+368.85%
AUM
$722M
AUM Growth
-$49.3M
(-6.4%)
Cap. Flow
-$37.2M
Cap. Flow
% of AUM
-5.16%
Top 10 Holdings %
Top 10 Hldgs %
52.39%
Holding
67
New
7
Increased
19
Reduced
27
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$24.4M |
| 2 |
AGU
Agrium
AGU
|
+$17.6M |
| 3 |
Royal Bank of Canada
RY
|
+$16.8M |
| 4 |
Apple
AAPL
|
+$16.7M |
| 5 |
Wells Fargo
WFC
|
+$13.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$32.3M |
| 2 |
Union Pacific
UNP
|
+$28.1M |
| 3 |
WRK
WestRock Company
WRK
|
+$23.6M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$22.2M |
| 5 |
Bank of America
BAC
|
+$22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.45% |
| 2 | Energy | 15.8% |
| 3 | Consumer Discretionary | 13.53% |
| 4 | Healthcare | 13.42% |
| 5 | Consumer Staples | 8.02% |
Similar funds
MDSL
CC
MCM
B
WGAM
HCM
CCP
MIM
Cumberland Partners's Q1 2016 Portfolio in Review
As of Q1 2016, Cumberland Partners held 67 positions worth $722M, down 6.4% from $771M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Cumberland Partners withdrew a net $37.2M in Q1 2016, closing 9 positions and reducing 27 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $32.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 36% a quarter earlier, followed by Energy and Consumer Discretionary.
Against the trend, Cumberland Partners opened a new position in Agrium worth $18.1M.
- Cumberland Partners's largest Q1 2016 buy was Agrium: 204,245 shares worth $18.1M.
- Cumberland Partners added most to SLB Ltd in Q1 2016, an estimated $24.4M increase.
- Cumberland Partners's biggest Q1 2016 reduction was WestRock Company, cutting an estimated $23.6M.
- Cumberland Partners fully exited Alexion Pharmaceuticals in Q1 2016, selling an estimated $32.3M.
- Cumberland Partners's ten largest holdings make up 52% of its $722M portfolio in Q1 2016.
- Cumberland Partners opened 7 new positions and closed 9 in Q1 2016.
- Cumberland Partners's portfolio value fell 6.4% quarter-over-quarter to $722M.
Based on Cumberland Partners's 13F filing for Q1 2016, filed 10 May 2016.